In colorectal cancer, HO-1 activity has been evaluated as a part of the antioxidant capacity of patients to determine whether a defined exercise program can improve recovery and reduce complications after surgery (NCT02264496). The gene discussed is HMOX1; the disease is colorectal cancer.